Helen McGuire

Title: Helen McGuire: Innovator in Beta-Lactamase Inhibitor Compounds

Introduction

Helen McGuire is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as beta-lactamase inhibitors. Her work is crucial in the fight against bacterial infections, especially those caused by drug-resistant organisms.

Latest Patents

Helen McGuire holds a patent for beta-lactamase inhibitor compounds. The present invention is directed to compounds that are beta-lactamase inhibitors. These compounds, along with their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics or alone for treating bacterial infections, including those caused by multi-drug resistant organisms.

Career Highlights

Helen is currently associated with Entasis Therapeutics, Inc., where she continues to innovate in the pharmaceutical sector. Her work focuses on developing effective treatments for challenging bacterial infections.

Collaborations

Some of her notable coworkers include Shanta Bist and Neil Bifulco, who contribute to the collaborative efforts at Entasis Therapeutics, Inc.

Conclusion

Helen McGuire's contributions to the field of beta-lactamase inhibitors highlight her role as a key innovator in pharmaceutical research. Her work is vital in addressing the challenges posed by drug-resistant bacterial infections.